Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AstraZeneca
AstraZeneca
PROpel study backs Lynparza combo in first-line prostate cancer
Pharmaforum
Fri, 09/24/21 - 11:06 am
AstraZeneca
Merck
Lynparza
clinical trials
prostate cancer
AstraZeneca makes RNA play, teaming up with startup to advance twist on red-hot modality
Fierce Biotech
Thu, 09/23/21 - 11:06 am
AstraZeneca
RNA
vaccines
VaxEquity
Pfizer, Moderna, AZ and other COVID vaccine companies face urgent calls to ramp up access around the world
Fierce Pharma
Wed, 09/22/21 - 11:59 am
vaccines
COVID-19
Amnesty International
AstraZeneca
BioNTech
JNJ
Moderna Therapeutics
Novavax
Pfizer
intellectual property
AstraZeneca lays out $360M for 'next-gen' manufacturing plant in Dublin
Fierce Pharma
Tue, 09/21/21 - 10:50 pm
AstraZeneca
Alexion
Ireland
drug manufacturing
ESMO 2021 – Astra coasts towards a new lung cancer combo
EP Vantage
Mon, 09/20/21 - 10:54 pm
ESMO
AstraZeneca
Imfinzi
oleclumab
Innate Pharma
non-small cell lung cancer
AstraZeneca, Daiichi Sankyo's ADC Enhertu blows away Roche's Kadcyla in second-line advanced breast cancer
Endpoints
Sat, 09/18/21 - 08:34 pm
ESMO
AstraZeneca
Daiichi Sankyo
Enhertu
breast cancer
Roche
ESMO21: Roche’s giredestrant takes stage in battle of the oral SERDs
Pharmaforum
Fri, 09/17/21 - 11:36 am
Roche
Giredestrant
Serds
breast cancer
ESMO
AstraZeneca
Faslodex
AstraZeneca touts Imfinzi immunotherapy combos for lung cancer in push to drive PD-L1 drug uptake
Endpoints
Fri, 09/17/21 - 10:58 am
AstraZeneca
Imfinzi
lung cancer
WCLC: AstraZeneca's detailed Imfinzi, tremelimumab data in metastatic NSCLC are far from a clear-cut win
Fierce Pharma
Fri, 09/10/21 - 11:05 am
WCLC
AstraZeneca
tremelimumab
metastatic non-small cell lung cancer
Aiming to uproot the market for asthma attacks, AstraZeneca and Avillion tout two PhIII wins for inhaled combo drug
Endpoints
Thu, 09/9/21 - 10:58 am
AstraZeneca
Avillion
asthma
severe asthma
clinical trials
PT027
AZ CEO Soriot urges caution on COVID booster doses
Pharmaforum
Wed, 09/8/21 - 11:09 am
AstraZeneca
vaccines
COVID-19
Pascal Soriot
Pharma CEOs
boosters
Amgen builds case for severe asthma drug tezepelumab
Pharmaforum
Mon, 09/6/21 - 09:11 pm
Amgen
AstraZeneca
tezepelumab
asthma
nasal polyps
AstraZeneca and Thermo Fisher Partner to Match Patients to Precision Therapies
BioSpace
Thu, 09/2/21 - 09:13 am
AstraZeneca
Thermo Fisher
next-generation gene sequencing
diagnostics
After Ultomiris stumble, Alexion delivers a rare disease win for AZ
Pharmaforum
Thu, 08/26/21 - 11:09 am
AstraZeneca
Alexion
ALXN1840
Wilson disease
Gilead, Regeneron, AstraZeneca and more encourage FDA to expand patient reported outcome guidance
Endpoints
Mon, 08/23/21 - 11:07 am
Gilead Sciences
Regeneron
AstraZeneca
FDA
PROs
oncology
clinical trials
patient-reported outcomes
AZ’s Alexion takeover hits a snag, as Ultomiris flunks ALS trial
Pharmaforum
Sun, 08/22/21 - 09:50 pm
AstraZeneca
Ultomiris
ALS
AstraZeneca antibody cocktail slashes risk of symptomatic COVID-19, setting up regulatory filings and a lifeline for the immunosuppressed
Fierce Biotech
Fri, 08/20/21 - 10:53 am
AstraZeneca
antibodies
COVID-19
clinical trials
AZD7442
Study adds insight on 'rare but devastating' blood clots after AstraZeneca shot
Beckers Hospital Review
Fri, 08/13/21 - 11:00 am
AstraZeneca
blood clots
COVID-19
vaccines
AstraZeneca and Daiichi Sankyo continue to flesh out Enhertu plans, claiming win in earlier breast cancer line
Endpoints
Mon, 08/9/21 - 10:55 am
AstraZeneca
Daiichi Sankyo
Enhertu
breast cancer
AstraZeneca chief Soriot lends GlaxoSmithKline's Walmsley CEO wisdom, support as activist investors press for change
Fierce Pharma
Fri, 08/6/21 - 11:10 am
Pharma CEOs
GSK
AstraZeneca
Emma Walmsley
Pascal Soriot
Pages
« first
‹ previous
…
24
25
26
27
28
29
30
31
32
…
next ›
last »